News

Novartis allies with Microsoft and focuses on artificial intelligence

The collaboration will lead to the creation of a laboratory, the Novartis Ai Innovation La

Tio 20 Ticino – 1.10.2019

BASEL – The pharmaceutical group Novartis and the American company Microsoft have entered into a collaboration in the field of artificial intelligence.

TLB courtesy: 12/11/2018 – Imagoeconomica|

The alliance envisages a multi-year commitment to research and development, a strategic collaboration which – explains the Basel giant in today's press release – leads to the creation of a laboratory (Novartis Ai Innovation Lab).

"Combining our deep understanding of human biology and medicine with Microsoft's unique capabilities in artificial intelligence will enable us to transform the way we discover and develop medicines for patients around the world," said CEO Vas Narasimhan, mentioned in the note.

Related news: Novartis and Microsoft join forces to develop drugs using AI

 

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Guarda anche
Close
Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco